title: Four-week repeated inhalation study of HCFC 225ca and HCFC 225cb in the common marmoset.
abstract: Four male and three female marmosets in each group were exposed to air only, 1000 ppm of HCFC 225ca or 5000 ppm of HCFC 225cb, for 6 h per day for 28 consecutive days. HCFC 225ca caused a slight reduction in body weight. HCFC 225cb occasionally caused somnolence during exposure and vomiting on the first day of exposure. Clinical chemistry findings included a mild reduction of triglyceride, cholesterol and phospholipid levels and increased GOT level in the HCFC 225ca exposure group. HCFC 225cb also caused a reduction of triglyceride levels in some animals. HCFC 225ca caused a slight increase of hepatic carnitine palmitoyltransferase (CPT) activity while HCFC 225cb slightly increased cyanide-insensitive palmitoyl CoA beta-oxidation (FAOS) activity. In the HCFC 225cb exposure group, an increase in cytochrome P-450 content was also observed. HCFC 225ca caused a fatty change in the hepatic cells. Increased incidence of lipid droplets in the hepatic cells and myelin-like bodies in hepatic cells, Kupffer's cells and hepatic blood vessels were observed electron microscopically in the HCFC 225ca exposure group. A proliferation of smooth endoplasmic reticulum was observed in the HCFC 225cb exposure group. Decreased peroxisome volume density in the HCFC 225ca group, and increased volume density in the HCFC 225cb exposed females were seen. However, organ weight measurement and histopathological examination did not reveal hepatomegaly or hypertrophy with either substance. Although slight changes were noticed in peroxisome volume density and in some of the peroxisomal enzyme activities, the changes related to peroxisome proliferation with HCFC 225ca and 225cb were minimal in marmosets compared to those seen in rats. Histopathological examination and hormonal analysis did not reveal any abnormalities in the pancreas or testes.
authors.affiliation: Mitsubishi Chemical Safety Institute, Ibaraki, Japan.
authors.forename: Y
authors.initials: Y
authors.lastname: Kurata
authors.forename: M
authors.initials: M
authors.lastname: Takechi
authors.forename: N
authors.initials: N
authors.lastname: Toyota
authors.forename: M
authors.initials: M
authors.lastname: Tsuchitani
authors.forename: M
authors.initials: M
authors.lastname: Katoh
authors.forename: G M
authors.initials: GM
authors.lastname: Rusch
authors.forename: H J
authors.initials: HJ
authors.lastname: Trochimowicz
authors.forename: S
authors.initials: S
authors.lastname: Shin-Ya
mesh_terms: D000280:Administration, Inhalation; D000818:Animals; D001835:Body Weight / Q000187:drug effects; D002144:Callithrix; D017402:Chlorofluorocarbons / Q000008:administration & dosage / Q000633:toxicity*; D005260:Female; D008099:Liver / Q000187:drug effects* / Q000473:pathology / Q000648:ultrastructure; D008297:Male; D008830:Microbodies / Q000187:drug effects
chemical_list: D017402:Chlorofluorocarbons; C076684:HCFC 225